Could psychedelics help patients in therapy?

After the FDA rejected MDMA‑assisted therapy in 2024, a lot of concerns were raised in 2025 about how the decision was assessed, the evaluation was made, and many criticisms came to light. The challenge is that psychedelic therapy doesn’t fit our current medical model. It’s not just a drug; it requires psychotherapy, structure, and regulation that the system isn’t built for. yet proposals on how to do this has been suggested. Other countries are moving ahead, but the UK is still behind. The conv